Late Mycobacterium bovis spondylitis after intravesical BCG therapy

Joint Bone Spine

Volumn 76, Issue 3, 2009, Pages 296-300

  Mavrogenis, Andreas F ^a   Sakellariou, Vasileios I ^a   Tsiodras, Sotirios ^a   Papagelopoulos, Panayiotis J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Abscess; Intravesical BCG therapy; M. bovis; Spinal infection

Indexed keywords

BCG VACCINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ABSCESS; AGED; ARTICLE; BLADDER CANCER; CASE REPORT; CLINICAL EXAMINATION; CYSTECTOMY; HISTOPATHOLOGY; HUMAN; INTERVERTEBRAL DISK; LEG PAIN; LOW BACK PAIN; MALE; MYCOBACTERIUM BOVIS; NEEDLE BIOPSY; OSTEOLYSIS; SPINE RADIOGRAPHY; SURGICAL APPROACH; SURGICAL TECHNIQUE; THORACOLUMBAR SPINE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUBERCULOUS SPONDYLITIS;

ADMINISTRATION, INTRAVESICAL; AGED; ANTITUBERCULAR AGENTS; BCG VACCINE; DRUG THERAPY, COMBINATION; EPIDURAL ABSCESS; ETHAMBUTOL; HUMANS; ISONIAZID; LUMBAR VERTEBRAE; MALE; MYCOBACTERIUM BOVIS; OSTEOLYSIS; OSTEOMYELITIS; RIFAMPIN; SPINAL FUSION; TREATMENT OUTCOME; TUBERCULOSIS, SPINAL;

EID: 67349254958     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.10.011     Document Type: Article

References (15)

1. Talbot E.A., Perkins M.D., Silva S.F., et al. Disseminated bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis 24 (1997) 1139-1146
2. Casanova J.L. Infections caused by BCG and atypical mycobacteria in children: a new group of immune deficiencies. Arch Pediatr 6 (1999) 139-140
3. Rischmann P., Desgrandchamps F., Malavaud B., et al. BCG intravesical instillations: recommendations for side-effects management. Eur Urol 37 Suppl. 1 (2000) 33-36
4. Abu-Nader R., and Terrell C.L. Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical BCG use. Mayo Clin Proc 77 (2002) 393-397
5. Clavel G., Grados F., Lefauveau P., et al. Osteoarticular side effects of BCG therapy. Joint Bone Spine 73 (2006) 24-28
6. Fishman J.R., Walton D.T., Flynn N.M., et al. Tuberculous spondylitis as a complication of intravesical bacillus Calmette-Guérin therapy. J Urol 149 (1993) 584-587
7. Guerra C.E., Betts R.F., O'Keefe R.J., et al. Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer. Clin Infect Dis 27 (1998) 639-640
8. Sugita Y., Chokyu H., Gotoh A., et al. Tuberculous spondylitis after intravesical BCG instillation: a case report. Nippon Hinyokika Gakkai Zasshi 86 (1995) 1493-1496
9. Bowyer L., Hall R.R., Reading J., et al. The persistence of bacille Calmette-Guérin in the bladder after intravesical treatment of bladder cancer. Br J Urol 75 (1995) 188-192
10. Durek C., Richter E., Basteck A., et al. The fate of bacillus Calmette-Guérin after intravesical instillation. J Urol 165 (2001) 1765-1768
11. Hakim S., Heaney J.A., Heinz T., et al. Psoas abscess following intravesical bacillus Calmette-Guérin for bladder cancer: a case report. J Urol 150 (1993) 188-189
12. Katz D.S., Wogalter H., D'Esposito R.F., et al. Mycobacterium bovis vertebral osteomyelitis and psoas abscess after intravesical BCG therapy for bladder carcinoma. Urology 40 (1992) 63-66
13. Seelig M.H., Oldenburg W.A., Klingler P.J., et al. Mycotic vascular infections of large arteries with Mycobacterium bovis after intravesical bacillus Calmette-Guérin therapy: case report. J Vasc Surg 29 (1999) 377-381
14. Altare F., Durandy A., Lammas D., et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280 (1998) 1432-1435
15. Talbot E.A., Williams D.L., and Frothingham R. PCR identification of Mycobacterium bovis BCG. J Clin Microbiol 35 (1997) 566-569